CPDE18358 - Vasodilating β-blockers for hypertension

Medcomet

This module is centred on the role of β-blockers in the management of hypertension, in line with recommendations from the ESC and the ESH, as well as highlights the salience and clinical efficacy of nebivolol in the management of hypertension.

This Continuous Medical Education (CME) is supported by Menarini Singapore Ptd Ltd.

You must be a member to access this content.

To become a member, please register here.

If you're already a member, please sign in to access.